Eyenovia's - EYEN market analysis on 31st October 2020

Transaction Date	Recipient	Shares	Type	Price	Value
12th October 2020	Stuart M. Grant	50,000	Open or private purchase	$3.60	$180,000.00
12th October 2020	Stuart M. Grant	50,000	Open or private purchase	$3.50	$175,000.00
24th September 2020	Stuart M. Grant	25,000	Open or private purchase	$2.98	$74,500.00
24th September 2020	Stuart M. Grant	50,000	Open or private purchase	$3.00	$150,000.00
18th September 2020	Jennifer G Clasby	26,737	Exercise of derivative	$1.95	$52,137.15
11th September 2020	Anthony Y Sun	7,288	Grant/award etc.	$0.00
11th September 2020	Charles E Iv Mather	7,288	Grant/award etc.	$0.00
11th September 2020	Fredric N Eshelman	7,288	Grant/award etc.	$0.00
11th September 2020	Kenneth B Jr Lee	7,288	Grant/award etc.	$0.00
11th September 2020	Ernest Mario	7,288	Grant/award etc.	$0.00

Eyenovia

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.

Edenovia, Inc. engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine.

Ticker: EYEN

Sector: Healthcare

Industry: Biotechnology

SEC Central Index Key (CIK): 1682639

Employees: 24

Exchange: NASDAQ

Auditor Opinion:

You must Login to see Language Changes

Disclosure Language changes

Analysis of subtle changes in disclosure language. Red is a sign of more constrained, less positive language changes etc. Green is more positive, less constrained etc.

You must Login to see analysis